The effect of transdermal estradiol or oral conjugated oestrogen and fenretinide versus placebo on haemostasis and cardiovascular risk biomarkers in a randomized breast cancer chemoprevention trial

BACKGROUND: We have previously reported the favourable effect of transdermal estradiol (E2), relative to oral conjugated equine oestrogen (CEE), on ultrasensitive C-reactive protein after 12 months of treatment in a retinoid-placebo controlled two-by-two randomized breast cancer prevention trial (De...

Descripción completa

Detalles Bibliográficos
Autores principales: Lazzeroni, M, Macis, D, Decensi, A, Gandini, S, Sandri, MT, Serrano, D, Guerrieri-Gonzaga, A, Johansson, H, Mora, S, Daldoss, C, Omodei, U, Bonanni, B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3234057/
https://www.ncbi.nlm.nih.gov/pubmed/22275964
http://dx.doi.org/10.3332/ecancer.2008.67

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3234057/
https://www.ncbi.nlm.nih.gov/pubmed/22275964
http://dx.doi.org/10.3332/ecancer.2008.67

Ejemplares similares